SEMA4B
Semaphorin-4B
Also known as: KIAA1745, MGC131831, SEM4B_HUMAN, SEMAC, SemC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPR2
- Gene
- SEMA4B
- Ensembl
- ENSG00000185033
- Chromosome
- 15
- Canonical length
- 837 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cell Junctions
OverviewNCBI Gene
Predicted to enable chemorepellent activity; neuropilin binding activity; and semaphorin receptor binding activity. Predicted to be involved in several processes, including axon guidance; neural crest cell migration; and semaphorin-plexin signaling pathway. Predicted to be located in membrane and synapse. Predicted to be active in glutamatergic synapse and postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
837 residues, UniProt reviewed canonical sequence.
>Q9NPR2|SEMA4B
1 MLRTAMGLRS WLAAPWGALP PRPPLLLLLL LLLLLQPPPP TWALSPRISL PLGSEERPFL
61 RFEAEHISNY TALLLSRDGR TLYVGAREAL FALSSNLSFL PGGEYQELLW GADAEKKQQC
121 SFKGKDPQRD CQNYIKILLP LSGSHLFTCG TAAFSPMCTY INMENFTLAR DEKGNVLLED
181 GKGRCPFDPN FKSTALVVDG ELYTGTVSSF QGNDPAISRS QSLRPTKTES SLNWLQDPAF
241 VASAYIPESL GSLQGDDDKI YFFFSETGQE FEFFENTIVS RIARICKGDE GGERVLQQRW
301 TSFLKAQLLC SRPDDGFPFN VLQDVFTLSP SPQDWRDTLF YGVFTSQWHR GTTEGSAVCV
361 FTMKDVQRVF SGLYKEVNRE TQQWYTVTHP VPTPRPGACI TNSARERKIN SSLQLPDRVL
421 NFLKDHFLMD GQVRSRMLLL QPQARYQRVA VHRVPGLHHT YDVLFLGTGD GRLHKAVSVG
481 PRVHIIEELQ IFSSGQPVQN LLLDTHRGLL YAASHSGVVQ VPMANCSLYR SCGDCLLARD
541 PYCAWSGSSC KHVSLYQPQL ATRPWIQDIE GASAKDLCSA SSVVSPSFVP TGEKPCEQVQ
601 FQPNTVNTLA CPLLSNLATR LWLRNGAPVN ASASCHVLPT GDLLLVGTQQ LGEFQCWSLE
661 EGFQQLVASY CPEVVEDGVA DQTDEGGSVP VIISTSRVSA PAGGKASWGA DRSYWKEFLV
721 MCTLFVLAVL LPVLFLLYRH RNSMKVFLKQ GECASVHPKT CPVVLPPETR PLNGLGPPST
781 PLDHRGYQSL SDSPPGSRVF TESEKRPLSI QDSFVEVSPV CPRPRVRLGS EIRDSVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SEMA4B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 120 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 120 nTPM
- vagina: 59 nTPM
- skin: 50 nTPM
- colon: 47 nTPM
- cervix: 46 nTPM
- kidney: 43 nTPM
Single-cell type
- urothelial cells: 419 nCPM
- prostatic hillock cells: 285 nCPM
- esophageal suprabasal cells: 278 nCPM
- ocular epithelial cells: 245 nCPM
- esophageal apical cells: 200 nCPM
- papillary tip epithelial cells: 184 nCPM
Immune cell
- memory B-cell: 17 nTPM
- naive B-cell: 15 nTPM
- neutrophil: 5.2 nTPM
- non-classical monocyte: 2.8 nTPM
- classical monocyte: 2.4 nTPM
- total PBMC: 1.5 nTPM
Brain region
- white matter: 44 nTPM
- midbrain: 41 nTPM
- medulla oblongata: 39 nTPM
- thalamus: 38 nTPM
- basal ganglia: 35 nTPM
- spinal cord: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.96
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- negative chemotaxis
- neural crest cell migration
- positive regulation of cell migration
- semaphorin-plexin signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SEMA4B as an antibody target. Whether an autoantibody or antibody against SEMA4B could matter depends on whether native SEMA4B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SEMA4B is annotated at the cell surface, where native SEMA4B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SEMA4B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...